4//SEC Filing
Patni Rajiv 4
Accession 0001209191-19-024240
CIK 0001328143other
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 4:26 PM ET
Size
7.6 KB
Accession
0001209191-19-024240
Insider Transaction Report
Form 4
Patni Rajiv
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-04-08+60,000→ 60,000 totalExercise: $6.81Exp: 2029-04-07→ Common Stock (60,000 underlying) - Award
Common Stock
2019-04-08+30,000→ 49,141 total
Footnotes (2)
- [F1]The shares of Common Stock are to be acquired upon the vesting of certain Restricted Stock Units granted to the Reporting Person. The Restricted Stock Units shall vest as follows: 25% of the total number of Restricted Stock Units will vest on each of March 20, 2020, March 20, 2021, March 20, 2022 and March 20, 2023, subject to Reporting Person's Continuous Service as of each such date.
- [F2]The Option shares shall vest as follows: 1/48th of the option shares shall vest on the 1st of each month beginning with May 1, 2019, subject to Reporting Person's Continuous Service as of each such date.
Documents
Issuer
Adamas Pharmaceuticals Inc
CIK 0001328143
Entity typeother
Related Parties
1- filerCIK 0001616200
Filing Metadata
- Form type
- 4
- Filed
- Apr 9, 8:00 PM ET
- Accepted
- Apr 10, 4:26 PM ET
- Size
- 7.6 KB